Cases 61 - 70 of 108
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED v. APOTEX INC.
as 1:2019cv14474
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED
Defendant:
APOTEX INC.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. APOTEX INC.
as 2:2019cv13994
Plaintiff:
CELGENE CORPORATION
Defendant:
APOTEX INC.
Cause Of Action: 15 U.S.C. § 1126
Pfizer Inc. et al v. Apotex Inc. et al.
as 1:2019cv00747
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Apotex Corp. and Apotex Inc.
Cause Of Action: 35 U.S.C. § 271
Vanda Pharmaceuticals Inc. v. Apotex Inc. et al
as 1:2019cv00685
Defendant:
Apotex Corp. and Apotex Inc.
Plaintiff:
Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Indivior Inc. et al v. Aveva Drug Delivery Systems, Inc. et al
as 0:2019cv60757
Plaintiff:
Indivior UK Limited, Aquestive Therapeutics, Inc. and Indivior Inc.
Defendant:
Aveva Drug Delivery Systems, Inc., Apotex Corp. and Apotex Inc.
Cause Of Action: 35 U.S.C. § 0271
CELGENE CORPORATION v. APOTEX INC.
as 2:2019cv06999
Plaintiff:
CELGENE CORPORATION
Defendant:
APOTEX INC.
Cause Of Action: 15 U.S.C. § 1126
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. APOTEX INC. et al
as 3:2019cv05939
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
APOTEX CORP. and APOTEX INC.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. APOTEX INC.
as 2:2019cv05806
Plaintiff:
CELGENE CORPORATION
Defendant:
APOTEX INC.
Cause Of Action: 15 U.S.C. § 1126
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
